Improving outcomes in people with cystic fibrosis

The research should determine how susceptible cystic fibrosis (CF) cells are to COVID-19, identify and evaluate responses to the virus in people with CF, and understand how commonly prescribed medications used in CF may alter responses to the virus. Letters of intent should be sent by 17 July.

Up to $125,000 USD per year
Agency or Funder
Eligibility (if available)

Applicants must be independent investigators

Foreign participation? (where known)
Date application deadline